TAMPA, Fla., Aug. 6 Gold Standard/Elsevier, publisher of medication management solutions, announced today the launch of three MedCounselor consumer drug information modules for pharmacies and health information Web sites. MedCounselor educates consumers on how to take medications safely, assists in identifying unknown tablets or capsules and checks for drug interactions. The modules are indispensable in helping to increase consumer compliance to their drug regimens and avoid costly and sometimes deadly medication errors.
Developed from Gold Standard/Elsevier's award-winning drug information and medication management content for health professionals, MedCounselor provides evidence-based, easily understandable consumer medication information.
"Pharmacies and health Web sites are on the front lines of healthcare, serving as accessible and familiar resources for consumers who want fast, accurate answers to their health questions," said Karl Matuszewski, MS, PharmD, Vice President and Editor-in-Chief at Gold Standard/Elsevier. "The sound, timely and useful information available through MedCounselor makes it a trusted resource that consumers will return to often for medication guidance and support."
MedCounselor's modules include:
MedCounselor also offers a new "Toolkit" which enables better integration with the client's existing content; clients can integrate searching and/or link to Drug Information directly from their own Web sites and applications.
Gold Standard/Elsevier will demonstrate these new MedCounselor modules at the NACDS Pharmacy & Technology Conference, August 8-11, 2009, in Boston, Booth #1166.
For more information on MedCounselor, please call 800-375-0943 or email email@example.com.
About Gold Standard
Based in Tampa, FL, Gold Standard/ELSEVIER uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Gold Standard/ELSEVIER solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Gold Standard/ELSEVIER, visit www.goldstandard.com.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
-- Drug Information: Updated "live"; covers need-to-know instructions for all commonly prescribed U.S. prescription drugs, plus hard-to-find information on herbals, vitamins and over-the-counter (OTC) products. -- Drug Interactions: Screens for interactions between prescription, OTC, herbal and nutritional products, as well as caffeine, food, tobacco and alcohol; severity rankings help to prioritize the alerts. -- Drug IDentifier: Assists consumers in identifying unknown tablets and capsules; allows for search by marking/imprint, shape and color; results include product descriptions and full-color drug images.
SOURCE Gold Standard/Elsevier